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Cognitively intact older individuals at risk for developing Alzheimer’s disease frequently show increased functional magnetic
resonance imaging (fMRI) brain activation presumably associated with compensatory recruitment, whereas mild cognitive
impairment (MCI) patients tend not to show increased activation presumably due to reduced neural reserve. Previous studies,
however, have typically used episodic memory activation tasks, placing MCI participants at a performance disadvantage relative
to healthy elders. In this event-related fMRI study, we employed a low effort, high accuracy semantic memory task to determine
if increased activation of memory circuits is preserved in amnestic MCI when task performance is controlled. Fifty-seven
participants, aged 65–85 years, comprised three groups (n = 19 each): amnestic MCI patients; cognitively intact older partici-
pants at risk for developing Alzheimer’s disease based on having at least one ApoE "4 allele and a positive family history of
Alzheimer’s disease (At Risk); and cognitively intact participants without Alzheimer’s disease risk factors (Control). fMRI was
conducted on a 3T MR scanner while participants performed a famous name discrimination task. Participants also underwent
neuropsychological testing outside the scanner; whole brain and hippocampal atrophy were assessed from anatomical MRI
scans. The three groups did not differ on demographic variables or on fame discrimination performance (487% correct for all
groups). As expected, the amnestic MCI participants demonstrated reduced episodic memory performance. Spatial extent of
activation (Fame—Unfamiliar subtraction) differentiated the three groups (Control = 0 ml, At Risk = 9.7 ml, MCI = 34.7 ml). The
MCI and At Risk groups showed significantly greater per cent signal change than Control participants in 8 of 14 functionally
defined regions, including the medial temporal lobe, temporoparietal junction, and posterior cingulate/precuneus. MCI partici-
pants also showed greater activation than Controls in two frontal regions. At Risk, but not MCI, participants showed increased
activity in the left hippocampal complex; MCI participants, however, evidenced increased activity in this region when hippo-
campal atrophy was controlled. When performance is equated, MCI patients demonstrate functional compensation in brain
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regions subserving semantic memory systems that generally equals or exceeds that observed in cognitively intact individuals at
risk for Alzheimer’s disease. This hyperactivation profile in MCI is even observed in the left hippocampal complex, but only
when the extent of hippocampal atrophy is taken into consideration.
Keywords: Area under the curve (AUC); fMRI; semantic memory; mild cognitive impairment; APOE "4
Abbreviations: DRS-2 = Mattis Dementia Rating Scale-2; fMRI = functional magnetic resonance imaging; GDS = Geriatric
Depression Scale; HRF = haemodynamic response function; MCI = mild cognitive impairment; RAVLT = Rey Auditory Verbal
Learning Test
Introduction
Objective biomarkers of Alzheimer’s disease have the potential
to make significant contributions to the timely detection and ther-
apeutic management of the disease (Mayeux, 2004; Sunderland
et al., 2006). Widely available, easily implemented, and cost-
effective biomarkers may have their greatest utility in early,
preclinical detection of Alzheimer’s disease (Chong and
Sahadevan, 2005; Chong et al., 2006). They may also play a
substantial role in monitoring therapeutic response to interventions
designed to slow disease progression (Chertkow and Black, 2007).
Recently, functional magnetic resonance imaging (fMRI), based on
blood oxygen dependent level (BOLD) contrast, has emerged as
a candidate biomarker for detecting early changes in the central
nervous system associated with Alzheimer’s disease. Unlike
anatomical imaging techniques, such as CT or MRI, or functional
metabolic approaches, such as SPECT or PET (glucose and amy-
loid), fMRI examines the brain’s response to cognitive challenges.
This ‘cognitive stress test’ approach to imaging holds the promise
of providing critically important data during the preclinical stage of
Alzheimer’s disease, especially if the selected task activates regions
known to be affected by the disease, such as the hippocampus,
posterior cingulate, and lateral temporoparietal regions (Petrella
et al., 2003, 2007).
Relatively few studies have investigated the relationship
between risk factors that may suggest susceptibility to the disease
and potential biomarkers that would imply the presence of the
disease (Schoonenboom et al., 2005). If fMRI is to be considered
as a valid biomarker for Alzheimer’s disease, it would be expected
to show predictable patterns in the presence of known risk factors
for the disease. In addition to age, two well-established risk factors
for Alzheimer’s disease are the presence of the e4 allele of
Apolipoprotein E (ApoE e4) and a family history of Alzheimer’s
disease. A diagnosis of mild cognitive impairment (MCI), often
considered a transitional stage between healthy ageing and
Alzheimer’s disease, confers even greater risk for developing the
disease. A stable and sensitive fMRI biomarker of progression
through the trajectory of early pathological changes would be
expected to be influenced by the nature and number of risk
factors. Such an indicator would be expected to be manifest in
high-risk individuals, but it could also be instrumental in evaluating
novel treatments designed to slow Alzheimer’s disease
progression.
Healthy adults with a family history of Alzheimer’s disease
or an ApoE e4 allele demonstrate altered patterns of fMRI
brain activation in the absence of any performance deficits
on neuropsychological tests (Smith et al., 1999; Bookheimer
et al., 2000; Burggren et al., 2002; Bondi et al., 2005; Celone
et al., 2006; Johnson et al., 2006b; Lind et al., 2006; Trivedi et al.,
2006; Wishart et al., 2006). Differences in BOLD fMRI activation
have also been seen in symptomatic MCI patients compared with
healthy controls (Dickerson et al., 2005; Celone et al., 2006;
Johnson et al., 2006a; Sandstrom et al., 2006; Vandenbulcke
et al., 2007), primarily in brain regions typically affected by patho-
logical changes in Alzheimer’s disease, including the hippocampus,
posterior cingulate, posterior lateral temporal and parietal cortices.
However, the pattern of group differences have been inconsistent,
with some studies showing increased activation in At Risk groups
(Bookheimer et al., 2000; Bondi et al., 2005; Dickerson et al.,
2005; Johnson et al., 2006b; Lind et al., 2006; Wishart et al.,
2006), whereas others have found hypoactivation (Smith
et al., 1999; Burggren et al., 2002; Johnson et al., 2006a;
Trivedi et al., 2006; Wishart et al., 2006; Vandenbulcke et al.,
2007).
The inconsistent findings involving MCI patients may be due to
differences in study design and methodology, since most of these
studies used effortful episodic memory tasks in which patient
performance during imaging was typically worse than that of a
healthy control group. When a patient group demonstrates poorer
performance on a cognitive task during functional imaging, it is
difficult to know whether differences in brain activation are due to
alterations in the functional neuronal response or to motivational
factors associated with lowered cognitive performance (Price and
Friston, 1999). This issue is compounded by the use of blocked
trial fMRI experimental designs that do not allow the elimination
of errors from the generation of the haemodynamic response
function (HRF) (Le et al., 2001; Hannula and Ranganath, 2008).
Furthermore, whereas effortful episodic memory tasks may be
valuable for demonstrating activation of memory circuits in
presymptomatic At Risk groups, such tasks would be less useful
for monitoring disease progression or treatment response in symp-
tomatic patients (MCI, Alzheimer’s disease), where performance is
already at basal levels (Small et al., 2008). Thus, an fMRI biomar-
ker using an episodic memory activation task would have limited
applicability across the spectrum of disease severity. When less
effortful memory tasks are used, significant relationships between
cognitive performance and regional brain activity have emerged
(Diamond et al., 2007). Therefore, the nature and complexity of
the cognitive task performed during scanning is a critical con-
sideration in the design of a useful fMRI biomarker.
In this event-related fMRI study, therefore, we used a low-
effort, high-accuracy semantic memory task, which requires
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patients to discriminate famous from unfamiliar names, to
compare activation in a group of MCI patients with that of healthy
older participants with and without Alzheimer’s disease risk fac-
tors. In our previous studies of cognitively intact older individuals,
we have shown that this fame discrimination task activates a
network consisting primarily of the medial temporal lobe (hippo-
campus), lateral temporoparietal and posterior cingulate regions
(Douville et al., 2005; Nielson et al., 2006; Woodard et al.,
2007). We predicted that when performance is equated, MCI
patients would demonstrate ‘hyperactivation’ in memory circuits
similar to that observed in At Risk healthy older adults.
Methods
Participants and procedure
Participants included 57 adults between the ages of 65 and 85 years
divided equally into three groups: 19 patients diagnosed with amnestic
MCI (‘MCI’ group), 19 cognitively intact individuals at risk for
developing dementia by virtue of having at least one ApoE e4 allele
and a positive family history (‘At Risk’ group) and 19 cognitively intact
individuals without ApoE e4 or family history risk factors (‘Control’
group).
The cognitively intact participants were recruited from a larger
sample of 459 community-dwelling adults who were recruited via
newspaper advertisements. Following telephone screening, 92 partici-
pants met study inclusion and exclusion criteria, and 81 persons
agreed to undergo ApoE genotyping from blood samples, a neurop-
sychological evaluation and an fMRI scanning session. Of these
participants, individuals with both a positive family history and at
least one ApoE e4 allele (n= 20) or those with neither risk factor
(n= 29) were included in this study. Family history was defined as a
report of a clear clinical diagnosis of Alzheimer’s disease or a reported
history of gradual decline in memory and other cognitive functions,
confusion, or judgement problems without a formal diagnosis of
Alzheimer’s disease prior to death in a first-degree relative. One
participant reported a diagnosis of Alzheimer’s disease in a second
degree relative, with some mild cognitive changes noted in a parent
prior to the parent’s death.
Participants from the At Risk and Control groups were matched to
the MCI participants on age, education and gender to form groups of
equal size. The At Risk and Control groups (n= 19 each) were formed
based on the presence/absence of at least one APOE "4 allele and a
family history of dementia. The At Risk group (FH + "4) had a family
history of dementia and one or both "4 alleles (18 "3/"4; 1 "4/"4).
The Control group did not have a family history of dementia and did
not possess an APOE "4 allele (1 "2/"3; 18 "3/"3).
The majority of MCI participants were recruited from the Memory
Disorders Clinic at the Medical College of Wisconsin. To be included in
the MCI group, participants met Petersen criteria (Petersen et al.,
2001): (i) memory complaint preferably corroborated by an informant;
(ii) objective memory impairment by neuropsychological testing (see
below); (iii) normal general cognitive functioning; (iv) intact activities
of daily living; and (v) not demented. MCI participants were also
evaluated by a neurologist with expertise in dementia to rule out
other possible bases for the memory impairment. All MCI participants
obtained a modified Hachinski ischemia score below 4. At Risk and
Control participants were required to perform within normal limits on
neuropsychological testing (see below).
Of the MCI group (n= 19), 59% were ApoE e4 positive (6 "3/"4;
4 "4/"4) and 63% were family-history positive; two of the 19 MCI
patients were taking cholinesterase inhibitors at the time of evaluation.
Informed consent was obtained according to the Declaration of
Helsinki and consistent with institutional guidelines established by
the Medical College of Wisconsin Human Subjects Review
Committee; all participants received financial compensation.
Any prospective participant was excluded if he/she reported any
previous or current history of neurological disease, major psychiatric
disturbance meeting DSM-IV Axis I criteria, substance abuse meeting
DSM-IV Axis I criteria, current use of psychoactive medications, or
any disturbance of activities of daily living. Any participant with an
anomaly on high resolution anatomical MRI scans also was excluded.
Additional exclusion criteria related to fMRI scanning included
pregnancy, weight inappropriate for height, ferrous objects within
the body, low visual acuity and a history of claustrophobia. A blood
chemistry screen (TSH, homocysteine, vitamin B12, folate and creati-
nine) was not found to be clinically significant in any of the
participants.
Neuropsychological testing and the fMRI scanning were conducted
on the same day. Participants were asked to refrain from alcohol use
24 h and caffeine use 12 h prior to testing. The neuropsychological test
battery consisted of the Mini-Mental State Examination (Folstein et al.,
1975), Mattis Dementia Rating Scale-2 (DRS-2); (Mattis, 1988; Jurica
et al., 2001), Rey Auditory Verbal Learning Test (RAVLT) (Rey, 1958),
Geriatric Depression Scale (GDS) (Yesavage et al., 1983) and Lawton
Activities of Daily Living (LADL) (Lawton and Brody, 1969). ApoE
genotype was determined using a PCR method (Saunders et al.,
1996). DNA was isolated with Gentra Systems Autopure LS for
Large Sample Nucleic Acid Purification.
To evaluate memory performance, local norms were collected from
91 healthy older adult subjects to establish cutoff scores for the
delayed recall and long-term percentage recall (LTPR) indices from
the Rey Verbal Learning Test. Separate cutoff scores were established
for men and women as there were significant sex differences in the
local group performance on the RAVLT. Using a criterion correspond-
ing to a performance of 1.5 standard deviation below the mean,
delayed recall of five words or lower for women and four words or
lower for men, and per cent retention scores below 60% were the
established cutoff scores used to identify the MCI group. All MCI
subjects scored below both these cutoff scores while all healthy
controls (see below) scored above these cutoff scores. In addition,
age and education corrected Mayo Older American Normative
Studies (MOANS) (Lucas et al., 1998) scaled scores of five or more
on the DRS-2 subscales (other than memory) were required for the
diagnosis of MCI, indicating an absence of dementia. All MCI subjects
obtained MMSE scores above 23. A score of516 for controls and520
for MCI participants on the GDS was required for inclusion in the
study in order to rule out moderate to severe depressive symptoms.
Finally, all MCI subjects scored in the normal range on a measure of
activities of daily living (LADL). Whenever possible, a collateral
reviewed participant responses.
Control and At Risk participants did not show deficits on the
Rey Auditory Verbal Learning Test (RAVLT; Rey, 1958) defined
as performance below 1.5 SD from their age and gender-adjusted
mean performance on the delayed recall and long-term per cent
retention measures. Similarly, Control and At Risk participants
showed no deficits on the Mattis Dementia Rating Scale-2, defined
as performance below 2 SD from their age- and education-adjusted
mean.
Groups were balanced for gender, age and education (Table 1).
One-way ANOVAs revealed no significant differences in activities of
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daily living (LADL) or the Construction and Conceptualization portions
of the DRS-2 global cognition battery. Inherent in the diagnosis of
MCI, expected group differences were seen on the MMSE, RAVLT
and Initiation/Perseveration, Attention and Memory portions of the
DRS-2. The only unanticipated group difference was on the GDS
(higher score in the MCI group; no participants, however, were
clinically depressed).
Functional MRI
fMRI task
The selection of famous name stimuli for this study is described in
greater detail in Douville et al. (2005). Briefly, the task stimuli
consisted of 30 names of famous persons who achieved their fame
either between 1990 and 2000 or between 1950 and 1965 and
30 names of unfamiliar individuals selected from an original pool of
784 names because of a high rate of correct identification (510%
error rate) (Douville et al., 2005). A trial consisted of the visual
presentation of a single name for 4 s. Participants were instructed to
make a right index finger key press if the name was famous and a
right middle finger key press if the name was unfamiliar. Both accuracy
(% correct) and reaction time (in milliseconds) were recorded; signal
detection indices, A’ and B’’, were calculated to examine discrimin-
ability and response bias (Grier, 1971). The 60 name trials were
randomly interspersed with 30 4-s trials in which the participant was
instructed to fixate a single centrally placed crosshair. This procedure
was done to introduce ‘jitter’ into the fMRI time course. The imaging
run began and ended with 12 s of fixation. Total time for the single
imaging run was 5 min and 24 s.
Image acquisition
Whole brain, event-related fMRI was conducted on a General Electric
(Waukesha, WI, USA) Signa Excite 3.0 Tesla short bore scanner
equipped with a quad split quadrature transmit/receive head coil.
Echoplanar images were collected using an echoplanar pulse sequence
[TE = 25 ms; flip angle = 77; field of view (FOV) = 24 mm; matrix
size = 6464]. Thirty-six contiguous axial 4-mm thick slices were
selected to provide coverage of the entire brain (voxel
size = 3.753.754 mm). The interscan interval (TR) was 2 s. High-
resolution, three-dimensional spoiled gradient-recalled at steady-state
(SPGR) anatomic images were acquired [TE = 3.9 ms; TR = 9.5 ms;
inversion recovery (IR) preparation time = 450 ms; flip angle = 12;
number of excitations (NEX) = 2; slice thickness = 1.0 mm;
Table 1 Group demographics, neuropsychological test results and fMRI task performance
Variables Control (n = 19) At Risk (n = 19) MCI (n = 19)
M SD M SD M SD P 2
Demographics
Age 75.1 5.9 72.1 3.9 75.4 6.9 NS 0.070
Education 14.0 2.4 15.3 2.7 14.1 2.4 NS 0.055
Gender (female/male) 15/4 15/4 15/4 NS –
Global cognition (DRS-2)
Total 139.8 3.6 140.5 3.6 130.4 7.2 50.001* 0.467
Attention 36.6 0.6 36.4 0.7 35.5 1.5 0.002* 0.206
Initiation/perseveration 36.8 0.7 36.5 1.0 34.1 3.0 50.001* 0.308
Construction 5.9 0.2 5.7 0.2 5.7 0.5 NS 0.091
Conceptualization 36.5 3.7 37.6 1.6 35.8 2.4 NS 0.069
Memory 24.0 1.1 24.1 1.4 19.2 4.3 50.001* 0.438
Total MOANS 11.9 2.2 11.8 2.7 7.3 3.7 50.001* 0.362
Mini-Mental State Exam 29.1 2.5 28.9 1.2 27.4 2.2 0.002* 0.205
Verbal learning (RAVLT)
Trials 1–5 48.0 5.2 50.6 8.5 28.7 7.9 50.001* 0.651
Post-interference recall 9.3 2.1 9.4 3.1 3.8 2.5 50.001* 0.520
Delayed recall 9.7 1.8 9.6 3.2 3.0 2.0 50.001* 0.640
Long-term per cent retentiona 87.0 15.4 78.3 19.7 43.6 25.7 50.001* 0.463
Learning over trialsb 16.7 5.6 17.5 6.7 7.6 5.4 50.001* 0.372
Depression
GDS 4.3 4.6 1.4 1.9 7.1 5.0 50.001** 0.251
Activities of daily living
Lawton 4.8 0.4 4.8 0.4 5.0 0.2 NS 0.042
fMRI task performance
Per cent correct—famous 90.9 7.1 92.5 8.4 87.4 14.6 NS 0.041
Per cent correct—unfamiliar 96.7 5.9 97.5 4.8 90.4 16.5 NS 0.090
Discriminability index (A’) 5.5 1.2 6.0 1.1 4.8 1.8 0.027** 0.125
Bias Index (B’’) 0.6 0.5 0.6 0.7 0.4 0.8 NS 0.070
Reaction time—famous (ms) 1293 229 1224 177 1334 242 NS 0.044
Reaction time—unfamiliar (ms) 1575 277 1573 311 1691 354 NS 0.031
a Long-term per cent retention (delayed recall/trial 5) 100.
b Learning over trials: sum of words recalled on trials 1-5  (trial 1 5).
* MCI5Control; MCI5At Risk.
** MCI5At Risk.
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FOV = 24 cm; resolution = 256224]. Foam padding was used to
reduce head movement within the coil.
Image analysis
Functional images were generated with the Analysis of Functional
NeuroImages (AFNI) software package (Cox, 1996). Each image
time series was time shifted to the beginning of the interscan interval
and then spatially registered to reduce the effects of head motion
using a rigid body iterative linear least squares method. A deconvolu-
tion analysis was used to extract a HRF for famous and unfamiliar
names from the time-series. HRFs were modeled for the 0–16 s
period post-stimulus onset. Motion parameters were incorporated
into the model as nuisance regressors. The HRFs were also transposed
so that the value of the HRF at trial onset was zero. Despite the high
task accuracy rate (see below), estimation of the HRFs for identifica-
tion of famous names and rejection of unfamiliar names was restricted
to correct trials. Area under the curve (AUC) was calculated by sum-
ming the hemodynamic responses at time points 4, 6 and 8 s post-trial
onset. We selected these time points because they yield optimal
contrast to noise in calculating the AUC. Individual anatomical and
functional scans were transformed into standard stereotaxic space
(Talairach and Tournoux, 1988). To compensate for normal variation
in anatomy across subjects, functional images were blurred using a
6 mm Gaussian full-width half-maximum filter.
Spatial extent analysis
This analysis was performed to examine within-group differences in
the spatial extent of activation comparing the Famous and Unfamiliar
name conditions. For each group, statistical parametric maps were
generated to identify voxels where the AUC for famous names
differed significantly from the AUC for unfamiliar names. An individual
voxel probability threshold (P= 0.001) was coupled with a minimum
cluster volume threshold of 0.28 ml. This combination of individual
voxel probability and minimum cluster size thresholds is equivalent
to a whole-brain family-wise error threshold of P50.05 based on
3000 Monte Carlo simulations (Forman et al., 1995).
Functional region of interest analysis
As a follow-up to the voxel-wise analyses, a functional region of
interest (fROI) analysis was conducted to evaluate potential group
differences in the magnitude of the AUC in functionally active regions.
A functional region of interest map was generated by conjoining
activated regions identified in the spatial extent analysis (see above)
across the three groups. Any voxel deemed ‘activated’ by the Famous-
Unfamiliar name subtraction in at least one of the three groups
contributed to the final functional region of interest map. For each
participant, an ‘averaged HRF’ was calculated for all voxels within a
functional region of interest. AUC (4, 6 and 8 s post-stimulus onset)
served as the dependent variable in a one-way analysis of variance
(ANOVA) to examine group differences in each functional region of
interest.
Structural MRI analyses
Voxel-based morphometry
Voxel-based morphometry (VBM) was conducted using SPGR anatom-
ical images segmented with SPM 5 (Ashburner et al., 2008). A cut-off
grey matter probability (P= 0.01) was used to remove spurious signals
at grey–white matter boundaries. Modulated, normalized grey matter
images were blurred using a 12 mm Gaussian filter to compensate for
normal variation in anatomy across subjects. A voxelwise, one-way
ANOVA (unpooled variance across subjects) was used to examine
differences in cortical atrophy across the three participant groups,
using a family-wise error threshold of P50.05.
Hippocampal volume
Left and right hippocampal volumes were manually traced on
T1-weighted SPGR images by two raters blinded to participant group
membership. Starting with a segmented mask of the medial temporal
region created using SPM 5 and overlaid on the anatomical image,
raters erased non-hippocampal regions on sagittal views. Using coronal
views, the mask is further refined by excluding the fimbria and alveus
and retaining the hippocampus (uncal apex, cornu ammonis,
subiculum, gyrus of retzius and fasciola cinerea). Hippocampal volumes
were normalized by dividing by the total intracranial volume. Intraclass
correlation for the two raters was 0.88. Hippocampal volumes were
also used as masks to calculate functional brain activation (see Results
section).
Results
fMRI task performance
All groups performed well on the Fame Discrimination task with
mean performance levels exceeding 87% correct (chance = 50%)
(Table 1). There were no statistically significant differences
between groups in per cent correct or reaction times for either
condition. A more sensitive signal detection measure,
Discriminability Index (A’), did reveal significant differences
between groups, although the effect size was relatively small.
For this reason, only correct trials were incorporated into the
fMRI analyses.
fMRI spatial extent analysis
Total volume of activation (Famous4Unfamiliar comparison) was
largest in the MCI group (34.7 ml) and intermediate in the At
Risk group (9.7 ml); the Control group showed no significant dif-
ferences in activation between the two stimulus conditions (Fig. 1,
Table 2). With a few exceptions, the MCI and At Risk groups
activated similar regions (bilateral posterior cingulate/precuneus,
and lateral temporoparietal regions, albeit smaller in volume in
the At Risk group relative to the MCI group. Small areas of
activation were observed in the frontal cortex and caudate in
the MCI group, which were not observed in the At Risk group.
Finally, activation was observed in the left hippocampus in the
At Risk group and the right hippocampus in the MCI group.
Functional ROI analysis
The fMRI mask (Fig. 2), formed by conjoining the activation maps
in Fig. 1, consisted of 14 functional regions of interest. Eight of the
14 regions, shown in yellow in Fig. 2, showed significant group
differences in the magnitude of activation, as reflected by per cent
MR signal intensity (blue regions did not show group differences).
Table 3 (post hoc analyses in rightmost column) and Fig. 3
illustrate that lateral temporoparietal and posterior cingulate/
precuneus regions showed a similar pattern of increased activation
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in both the At Risk and MCI groups relative to the Control group,
whereas increased activation in frontal regions (left middle frontal,
right SMA) was limited to the MCI group. In contrast, activation in
left hippocampus was increased only in the At Risk group.
In the right hippocampal region of interest, there were no group
differences in activation.
Table 2 Activation foci for famous versus unfamiliar name contrast for each group
Control At Risk MCI
No. Region BA x y z Vol. x y z Vol. x y z Vol.
Frontal
1 L Middle, superior frontal gyrus 6 22 13 51 1.48
2 R SMA 6, 31 12 26 47 0.59
3 L Middle frontal gyrus 6 37 1 54 0.44
4 L Middle frontal gyrus 6 26 6 60 0.31
Parietal
5 B Precuneus, posterior cingulate 7, 23, 30, 31 0 54 35 2.37 1 57 26 16.04
6 L Angular gyrus 19, 22, 39 42 63 25 11.19
7 R Angular gyrus, precuneus 13, 40 51 47 30 0.32 42 73 35 0.41
8 L Inferior parietal lobule 40 46 46 40 0.56
9 R Inferior parietal lobule 40 53 42 47 0.35
10 L Posterior cingulate 29, 30 4 54 6 0.53
Temporal
11 L Middle temporal, angular gyrus 19, 39 41 64 29 3.61
12 R Middle temporal gyrus 21, 22, 39 61 55 6 0.50 56 57 18 1.57
13 L Middle temporal gyrus 37 57 47 6 0.34
14 L Hippocampus  23 25 11 1.44
15 R Hippocampus  27 32 2 0.65
Basal Ganglia
16 L Caudate  10 9 11 1.65
Total Activation Volume 0 9.66 34.67
L = left, R = right.
Figure 1 Regions (shown in blue) demonstrating significant
differences between the Famous and Unfamiliar Name
conditions, conducted separately for each of the three groups.
Brain activation projected on the lateral and medial surfaces
of the left and right hemispheres. See Table 2 for additional
information relating to individual activation foci.
Figure 2 Functional ROIs derived from conjoining activation
maps in Fig. 1. Yellow regions indicate significant group
differences in the magnitude of the MR signal intensity
between groups; blue regions indicate no significant group
differences. See Table 3 for additional information relating
to individual fROIs.
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Voxel-based morphometry
VBM was used to evaluate potential group differences in brain
tissue density within the cortical grey matter. Only one significant
group difference was observed, a reduction in the left hippocam-
pus in the MCI participants compared to the At Risk and Control
groups (Fig. 4). No other brain region showed significant tissue
density reductions in the MCI group compared to the At Risk and
Control groups.
Hippocampal volumes
Results of hippocampal volumetric tracings are presented in
Fig. 5A (upper panel) and confirm the VBM findings: left
hippocampal volume was significantly reduced in MCI participants
compared to the At Risk and Control groups (P= 0.002); likewise,
there was a non-significant trend for the MCI group to have a
smaller right hippocampal volume than the two cognitively intact
groups (P= 0.069).
Figure 3 Mean (SEM) per cent MR signal intensity differences between the Famous and Unfamiliar Name conditions for the three
groups. HRFs for representative (A) positive and (B) negative fROIs. (A) Regions in which MCI and At Risk groups demonstrate greater
activation than the Control group; (B) MCI activation greater than Control activation; (C) MCI activation greater than At Risk and
Control activation; and (D) At Risk greater than MCI and Control activation.
Table 3 Functional ROIs resulting from conjunction of famous versus unfamiliar name contrasts
Region BA x y z Vol. P Post hoc’s
Frontal lobe
L Middle frontal gyrus 6, 8 22 13 51 1.5 NS
L Middle frontal gyrus 6 37 1 54 0.4 0.03 MCI4C
L Middle frontal, precentral gyrus 6 26 6 60 0.3 NS
Parietal lobe
B Posterior cingulate, precuneus 7, 31 1 56 27 16.6 0.05 AR4C, MCI4C
R SMA 5, 6, 31 12 26 47 0.6 0.003 MCI4AR, MCI4C
L Inferior parietal lobule 40 46 46 40 0.6 0.007 AR4C, MCI4C
R Angular gyrus 19, 39 42 73 35 0.4 NS
R Inferior parietal lobule 40 53 42 47 0.4 0.01 AR4C, MCI4C
R Angular, supramarginal gyrus 13, 40 51 47 30 0.3 0.008 AR4C, MCI4C
Temporal lobe
L Middle temporal, angular gyrus 19, 39, 40 43 62 25 12.0 NS
R Middle, superior temporal gyrus 21, 39 57 57 16 1.9 0.003 AR4C, MCI4C
L Hippocampus 23 25 11 1.4 0.03 AR4C, AR4MCI
R Hippocampus 27 32 2 0.7 NS
Basal ganglia
L Caudate 10 9 11 1.6 NS
L = left; R = right; NS = not significant; C = Controls; AR = At Risk.
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The functional ROI analysis presented above indicated that
activation in the left hippocampus was increased only in the At
Risk group. Since the same functional region of interest mask was
applied to all participants, it is conceivable that the reduced
activation within the hippocampus of the MCI group could be
due to atrophy. Figure 5B (lower panel) addresses this problem
by presenting the averaged mean per cent MR signal intensity
values for the left and right hippocampi based on the anatomically
defined regions of interest. When this correction was applied,
there were no significant differences in activation between the
MCI and At Risk groups within the left and right hippocampus
of the MCI participants.
Discussion
Our study demonstrated that increased activation of semantic
memory circuits is observed in persons with MCI when task
performance remains at levels comparable to healthy controls. In
fact, the spatial extent and magnitude of the BOLD response was
greater in the MCI group than that observed in cognitively intact
individuals with two known Alzheimer’s disease risk factors (family
history and ApoE "4 allele). Both the MCI and At Risk groups,
in turn, demonstrated greater activation than a Control group
consisting of cognitively intact older adults with no known risk
factors. Thus, our results suggest that persons with MCI show
evidence of functional compensation in brain regions subserving
semantic memory systems; the degree of compensation appearing
to be somewhat greater than that seen for healthy At Risk
individuals. This increased activation was particularly evident in
the posterior cingulate cortex, posterolateral parietal cortex, and
frontal cortex [right supplementary motor area (SMA) and left
middle frontal gyrus]. While functional connectivity disruptions
have been noted between posterior cingulate cortex and brain
Figure 5 (A) Mean (SEM) normalized volume of left and right hippocampus as a function of group. Brackets indicate significant
group differences. (B) Mean (SEM) per cent MR signal intensity for the left and right hippocampi (derived from anatomical tracings)
for each group.
Figure 4 Results of VBM analysis indicating a significant
difference in brain tissue density in the left hippocampus
(shown in red) of the MCI group relative to the Control and
At Risk groups.
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regions critical to memory performance in persons with
Alzheimer’s disease (Greicius et al., 2004; Zhou et al., 2008)
and in At Risk controls (Sorg et al., 2007), a recent study has
identified increased functional connectivity between the posterior
cingulate cortex and frontal-parietal cortices in persons with mild
Alzheimer’s disease (Zhang et al., 2008). This increase in func-
tional connectivity could account for the pattern of increased
activity seen in MCI patients and At Risk controls in our study.
The absence of within-group activation differences between
famous and unfamiliar names for the Control participants contrasts
with the intermediate activation in the At Risk group and greater
activation in the MCI group. Although the process of famous
name identification is typically done automatically and without
much conscious effort, cognitive models include distinct stages
of recognition and identification, which can be dissociable at
both the behavioural and neural levels. We previously reported
(Seidenberg et al., 2009) that MCI patients are unimpaired in
the recognition of famous names but show significant impairment
in the ability to access semantic knowledge about famous names
that they correctly recognized, compared to age matched controls.
It is possible that the healthy controls are able to proceed through
the stages of recognition and identification of famous and
unfamiliar names without disruption and, therefore, produce
similar levels of activation for both types of stimuli. In contrast,
the At Risk and MCI groups may have less automatic access to the
semantic stores of knowledge about the famous names. Subtle
neuropathological burden associated with increased disease risk
may begin to interfere with the neural circuitry associated with
semantic and episodic memory processing networks. Thus, the
neural circuitry associated with access to and retrieval of their
fine-grained semantic knowledge of famous individuals is more
challenged. As a result, the task may be more effortful for these
individuals and may produce increased activation relative to
controls.
On the basis of a functional ROI analysis, compensatory activa-
tion was observed in the left hippocampus in the At Risk group,
but apparently not in the MCI group. This finding may be an
artifact of the analysis approach, which defined the hippocampal
volume based on a conjunction mask of functional activity derived
from each of the three groups and applied to all study partici-
pants. A subsequent volumetric analysis revealed that the MCI
group had a significantly smaller left hippocampus than the two
cognitively intact groups, suggesting that the decreased activation
in the MCI group may have been the result of partial volume
effects due to atrophy rather than a true decrease in hippocampal
activity. When anatomical regions of interest were applied to
define the hippocampus on an individual participant basis, MCI
patients showed levels of activation comparable to the At Risk
group. Our results underscore the importance of evaluating func-
tional activation within the hippocampus using anatomical regions
of interest because of the propensity for this structure to become
atrophic in MCI.
The brain regions activated by our semantic task are similar to
the so-called default network (Greicius et al., 2004), which reflects
the state of the brain during rest. Binder and colleagues (Binder
et al., 1999; McKiernan et al., 2003) have suggested that the
resting state is not a passive state, but rather is characterized by
rich cognitive activity, including semantic memory processing. Our
event-related design permits a more systematic assessment of
semantic memory processes during our fame discrimination task
because we are comparing two active states: discrimination of
famous names (high semantic memory) relative to unfamiliar
names (low semantic memory). Because rest is, by definition, an
uncontrolled state, blocked trial fMRI designs employing rest as a
control condition cannot unambiguously separate the semantic
memory processes from the active states. In addition, carriers of
the ApoE e4 allele show diminished task-induced deactivation
relative to non-carriers in brain regions associated with the default
network during a semantic categorization task (Persson et al.,
2008). These reductions may suggest a propensity for the
increased activation that may underlie compensatory recruitment.
This cross-sectional study implies that regional brain activity
during a semantic memory task increases as the disease pro-
gresses. Longitudinal studies would be helpful in confirming
whether task-induced activation does indeed increase in propor-
tion to disease progression in an individual. If semantic memory
tasks do track progression, they could be used as a biomarker to
monitor disease progression or in treatment studies where reduced
activation may signal a decreased need for compensatory recruit-
ment. An obvious clinical application of our task would be its use
in assessing efficacy of novel interventions or for identifying
changes in the pattern of activation that may correspond to
worsening of the disease. Future research studies might investigate
whether our results using a semantic memory task involving
person identity might generalize to other approaches for assessing
semantic memory. That is, it will be important to determine
whether the effect found in our study is dependent on person
recognition specifically or semantic memory in general. In addition,
the extent to which our approach can differentiate persons with
single versus multiple-domain amnestic MCI would be of interest.
As noted earlier, prior fMRI studies of MCI and healthy controls
revealed discrepant findings. We assert that one possible explana-
tion for these divergent findings is that the majority of studies
used an episodic memory task that may have been overly challen-
ging for MCI participants. This type of difficulty would clearly
limit the ability of such a task to be useful in tracking disease
progression or response to pharmacological intervention in
patients with Alzheimer’s disease, who have even more severe
deficits in episodic memory. A second limitation of prior studies
may have been the use of blocked trial design fMRI paradigms,
which do not have the ability to separate correct trials from errors
in the imaging results. As a result, patients with memory disorders
may demonstrate a different pattern of activation simply because
their behaviour included more incorrect responses than controls.
That is, the neural activity likely reflects more ‘dysfunction’ than
‘function’ compared to controls. Discrepancies in the direction of
group activation differences among Alzheimer’s disease risk groups
may be a result of differences in the cognitive task used at base-
line. Cognitive tasks in which performance would be expected to
be more accurate and less variable over time may provide a more
consistent index of disease progression involving brain networks
subserving these cognitive skills.
Although our sample was intended to include persons with
amnestic MCI, the limited neuropsychological testing performed
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with them makes a clear distinction between single domain and
multiple-domain amnestic MCI difficult. Therefore, it is important
to recognize that our sample may represent a combination of
persons with single and multiple-domain amnestic MCI, which
may influence the risk of progression to Alzheimer’s disease and
the nature of the dementia itself.
Our results suggest that persons at increased risk for Alzheimer’s
disease, whether they have been diagnosed with MCI or are
healthy controls with multiple risk factors, display increased acti-
vation in posterior parietal and temporal regions while performing
a semantic memory task that involves the recognition of famous
people, a finding that is consistent with several other reports using
different cognitive tasks with At Risk groups, MCI patients or
Alzheimer’s disease patients (Woodard et al., 1998; Saykin
et al., 1999; Bookheimer et al., 2000; Bondi et al., 2005;
Dickerson et al., 2005; Johnson et al., 2006b; Lind et al., 2006;
Wishart et al., 2006; Han et al., 2008). This increased activity
associated with increasing disease severity appears to reflect
compensatory recruitment of neural resources, presumably due
to the neuropathological effects on brain regions that are critical
to performing the task of interest (Nielson et al., 2006; Han et al.,
2008). These activated regions are salient because they show con-
siderable overlap with the default state network—brain areas that
demonstrate greater activity during ‘rest’ conditions (Greicius
et al., 2004; van den Heuvel et al., 2008). In addition, unlike
prior studies that have made use of challenging episodic
memory tasks, our approach uses a semantic memory task that
even persons with impaired episodic memory impairment can per-
form with a high degree of accuracy. This advantage suggests that
our famous name discrimination task can be used to track demen-
tia progression even in cognitively impaired individuals. As noted
earlier, a strong candidate biomarker for Alzheimer’s disease
would be sensitive not only to the risk factors for developing
the disease, but also to the presence of cognitive impairment
that may be associated with the disease. We conclude that this
famous name recognition task has the potential to be used as a
biomarker of Alzheimer’s disease risk and progression, given the
increased compensatory activity seen in persons at genetic risk for
the disease and even greater compensation seen in persons with
mild cognitive impairment.
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